References

Decline in cardiovascular mortality: possible causes and implications

10.1161/circresaha.116.309115 · 2017 · External reference

Explaining the decrease in US deaths from coronary disease

10.1056/nejmsa053935 · 2007 · External reference

Heart disease mortality in the United States

10.1161/jaha.124.038644 · 2025 · External reference

Decline in deaths from heart disease and stroke–United States, 1900-1999

1999 · External reference

Acute lymphoblastic leukemia in children

10.1056/nejmra1400972 · 2015 · External reference

Global efforts toward the cure of childhood acute lymphoblastic leukaemia

10.1016/s2352-4642(18)30066-x · 2018 · External reference

Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000-2016

10.1001/jamanetworkopen.2020.7954 · 2020 · External reference

Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies

10.1016/s2352-3018(17)30066-8 · 2017 · External reference

The internal secretion of the pancreas

2007 · External reference

The changing tides of the type 2 diabetes epidemic–smooth sailing or troubled waters ahead? Kelly West Award Lecture 2016

10.2337/dci16-0055 · 2017 · External reference

Cancer statistics, 2024

10.3322/caac.21820 · 2024 · External reference

Where is the disease?

10.13140/rg.2.2.29549.76004 · 2026 · External reference

From lifespan to healthspan

10.1001/jama.2018.12621 · 2018 · External reference

Life expectancy and mortality rates in the United States, 1959–2017

10.1001/jama.2019.16932 · 2019 · External reference

Global burden of dementia death from 1990 to 2019, with projections to 2050: an analysis of 2019 global burden of disease study

10.14283/jpad.2024.21 · 2024 · External reference

Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the Global Burden of Disease Study 2019

10.1002/alz.051496 · 2022 · External reference

Alzheimer disease in the United States (2010-2050) estimated using the 2010 census

10.1212/wnl.0b013e31828726f5 · 2013 · External reference

Revisiting FDA approval of aducanumab

10.1056/nejmp2110468 · 2021 · External reference

The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics

10.1038/s41573-022-00391-w · 2022 · External reference

Aducanumab for Alzheimer's disease?

10.1136/bmj.n1682 · 2021 · External reference

Schizophrenia: from neurochemistry to circuits, symptoms and treatments

10.1038/s41582-023-00904-0 · 2024 · External reference

No support for historical candidate gene or candidate gene-by-interaction hypotheses for major depression across multiple large samples

10.1176/appi.ajp.2018.18070881 · 2019 · External reference

The serotonin theory of depression: a systematic umbrella review of the evidence

10.1038/s41380-022-01661-0 · 2023 · External reference

Origins and evolution of antibiotic resistance

10.1128/mmbr.00016-10 · 2010 · External reference

The epidemiologic transition: a theory of the epidemiology of population change

10.1111/j.1468-0009.2005.00398.x · 2005 · External reference

Regulation of the immune system by biodiversity from the natural environment: an ecosystem service essential to health

10.1073/pnas.1313731110 · 2013 · External reference

Hay fever, hygiene, and household size

10.1136/bmj.299.6710.1259 · 1989 · External reference

10.7551/mitpress/8328.001.0001

10.7551/mitpress/8328.001.0001 · 2010 · External reference

The dappled nature of causes of psychiatric illness: replacing the organic-functional/hardware-software dichotomy with empirically based pluralism

10.1038/mp.2011.182 · 2012 · External reference

10.1093/acprof:oso/9780199299317.001.0001

10.1093/acprof:oso/9780199299317.001.0001 · 2007 · External reference

The epistemic policies of anti-ageing medicines in the European Union

10.1007/s10728-024-00497-9 · 2024 · External reference

10.1017/cbo9780511802683

10.1017/cbo9780511802683 · 2003 · External reference

A network theory of mental disorders

10.1002/wps.20375 · 2017 · External reference

Brain disorders? Not really: why network structures block reductionism in psychopathology research

10.1017/s0140525x18002091 · 2019 · External reference

The need for a new medical model: a challenge for biomedicine

10.1126/science.847460 · 1977 · External reference

Causes

10.1093/oxfordjournals.aje.a112335 · 1976 · External reference

Causation and causal inference in epidemiology

10.2105/ajph.2004.059204 · 2005 · External reference

Causes and conditions

1965 · External reference

From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus

10.2337/db09-9028 · 2009 · External reference

Geroscience: linking aging to chronic disease

10.1016/j.cell.2014.10.039 · 2014 · External reference

Hallmarks of aging: an expanding universe

10.1016/j.cell.2022.11.001 · 2023 · External reference

World-Wide FINGERS network: a global approach to risk reduction and prevention of dementia

10.1002/alz.12123 · 2020 · External reference

A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial

10.1016/s0140-6736(15)60461-5 · 2015 · External reference

From dementia prevention research to global FINGER-based multi-domain interventions and implementation strategies

10.1016/j.cccb.2025.100385 · 2025 · External reference

Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review

10.1007/s00198-017-3980-9 · 2017 · External reference

Resistance training for older adults: position statement from the National Strength and Conditioning Association

10.1519/jsc.0000000000003230 · 2019 · External reference

Progressive resistance strength training for improving physical function in older adults

10.1002/14651858.cd002759.pub2 · 2009 · External reference

Global distribution of research efforts, disease burden, and impact of US public funding withdrawal

10.1038/s41591-025-03923-0 · 2025 · External reference

Rescuing US biomedical research from its systemic flaws

10.1073/pnas.1404402111 · 2014 · External reference

Addressing systemic problems in the biomedical research enterprise

10.1073/pnas.1500969112 · 2015 · External reference

The persistence of very low correlations between NIH research funding and disease burdens

10.1016/j.puhip.2024.100580 · 2025 · External reference

NIH disease funding levels and burden of disease

10.1371/journal.pone.0016837 · 2011 · External reference

Falsification and the methodology of scientific research programmes

10.1017/cbo9781139171434.009 · 1970 · External reference

Toward the future of psychiatric diagnosis: the seven pillars of RDoC

10.1186/1741-7015-11-126 · 2013 · External reference

Distal symmetric polyneuropathy: a review

10.1001/jama.2015.13611 · 2015 · External reference

The epidemiology and risk factors of chronic polyneuropathy

10.1007/s10654-015-0094-6 · 2016 · External reference

Emerging biomarkers, tools, and treatments for diabetic polyneuropathy

10.1210/er.2018-00107 · 2019 · External reference

Sauver JL, Dyck PJ, Klein CJ. Impairments and comorbidities of polyneuropathy revealed by population-based analyses

10.1212/wnl.0000000000001492 · 2015 · External reference

Causes of neuropathy in patients referred as “idiopathic neuropathy”

10.1002/mus.24969 · 2016 · External reference

Incidence of polyneuropathy in Utrecht, the Netherlands

10.1212/wnl.0000000000001160 · 2015 · External reference

Mitochondrial dynamics and peripheral neuropathy

10.1177/1073858407307354 · 2008 · External reference

Mechanisms of axon degeneration: from development to disease

10.1016/j.pneurobio.2007.07.007 · 2007 · External reference

Axo-glial interdependence in peripheral nerve development

10.1242/dev.151704 · 2019 · External reference

Diminished schwann cell repair responses underlie age-associated impaired axonal regeneration

10.1016/j.neuron.2014.06.016 · 2014 · External reference

Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy

10.1007/s001250100001 · 2001 · External reference

Role of advanced glycation end products in diabetic neuropathy

10.2174/138161208784139774 · 2008 · External reference

Metabolic syndrome components are associated with symptomatic polyneuropathy independent of glycemic status

10.2337/dc16-0081 · 2016 · External reference

Metabolic syndrome is related to polyneuropathy and impaired peripheral nerve function: a prospective population-based cohort study

10.1136/jnnp-2016-314171 · 2016 · External reference

The neuroinflammatory role of schwann cells in disease

10.1016/j.nbd.2013.03.005 · 2013 · External reference

Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis

10.1016/s1474-4422(14)70251-0 · 2015 · External reference

Oral and topical treatment of painful diabetic polyneuropathy: practice guideline update summary: report of the AAN guideline subcommittee

10.1212/wnl.0000000000013038 · 2022 · External reference

The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy

10.1016/j.jdiacomp.2012.05.007 · 2012 · External reference

Lifestyle intervention for pre-diabetic neuropathy

10.2337/dc06-0224 · 2006 · External reference

Exercise intervention studies in patients with peripheral neuropathy: a systematic review

10.1007/s40279-014-0207-5 · 2014 · External reference

Current concepts in the management of diabetic polyneuropathy

10.1111/jdi.13401 · 2021 · External reference

Sarcopenia: revised European consensus on definition and diagnosis

10.1093/ageing/afy169 · 2019 · External reference

Sarcopenia: aging-related loss of muscle mass and function

10.1152/physrev.00061.2017 · 2019 · External reference

Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial

10.1016/s2213-8587(15)00298-3 · 2015 · External reference

Treatment of sarcopenia with bimagrumab: results from a phase II, randomized, controlled, proof-of-concept study

10.1111/jgs.14927 · 2017 · External reference

A deep-learning framework reveals whole-body perturbations at cell level

10.1038/s41586-026-10535-2 · 2026 · External reference

Bevacizumab injection in patients with neovascular age-related macular degeneration increases angiogenic biomarkers

10.1016/j.oret.2017.04.004 · 2018 · External reference

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

10.1056/nejmoa1102673 · 2011 · External reference

Ranibizumab for neovascular age-related macular degeneration

10.1056/nejmoa054481 · 2006 · External reference

The divide-and-conquer approach to delaying age-related functional decline: where are we now?

10.1089/rej.2023.0057 · 2023 · External reference

SENS vs. the hallmarks of aging: competing visions, shared challenges

10.1007/s10522-025-10248-5 · 2025 · External reference

Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition

10.4161/cc.5.18.3288 · 2006 · External reference

The hoverfly and the wasp: a critique of the hallmarks of aging as a paradigm

10.1016/j.arr.2021.101407 · 2021 · External reference

A complex systems approach to aging biology

10.1038/s43587-022-00252-6 · 2022 · External reference

Evolution of ageing

10.1038/270301a0 · 1977 · External reference

Inflammaging: a new immune-metabolic viewpoint for age-related diseases

10.1038/s41574-018-0059-4 · 2018 · External reference

Distinguishing between driver and passenger mechanisms of aging

10.1038/s41588-023-01627-0 · 2024 · External reference

Targeting the “hallmarks of aging” to slow aging and treat age-related disease: fact or fiction?

10.1038/s41380-022-01680-x · 2023 · External reference

The Hallmarks of aging: paradigms and scientific progress

10.1016/j.arr.2026.103181 · 2026 · External reference

Targeting multiple hallmarks of mammalian aging with combinations of interventions

10.18632/aging.206078 · 2024 · External reference

Challenges in developing Geroscience trials

10.1038/s41467-023-39786-7 · 2023 · External reference

Can geroscience be translated into healthcare?

10.1007/s00391-024-02326-z · 2024 · External reference

10.1007/s11357-018-0042-y · 2018 · Admitted local publication

10.1093/9780197830062.001.0001

10.1093/9780197830062.001.0001 · 2026 · External reference

Is ageing undesirable? An ethical analysis

10.1136/jme-2022-108823 · 2023 · External reference

The ethics case for longevity science

10.1016/j.arr.2026.103054 · 2026 · External reference

10.7551/mitpress/14110.001.0001

10.7551/mitpress/14110.001.0001 · 2022 · External reference

Clashing perspectives? Two approaches to the desirability of biological aging

2026 · External reference

Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care

10.1093/gerona/59.3.m255 · 2004 · External reference

Designing health care for the most common chronic condition–multimorbidity

10.1001/jama.2012.5265 · 2012 · External reference

Prescribing for frail older people

10.18773/austprescr.2017.055 · 2017 · External reference

What is polypharmacy? A systematic review of definitions

10.1186/s12877-017-0621-2 · 2017 · External reference

Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence

10.1097/01.jgp.0000308883.64832.ed · 2008 · External reference

Dementia prevention, intervention, and care: 2024 report of the Lancet standing commission

10.1016/s0140-6736(24)01296-0 · 2024 · External reference

Measuring polarization changes in the human outer retina with polarization-sensitive optical coherence tomography

10.1002/jbio.201700134 · 2018 · External reference

Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no 35

10.1016/j.ophtha.2013.01.021 · 2013 · External reference

A double-masked, randomized, sham-controlled, single-center study with photobiomodulation for the treatment of dry age-related macular degeneration

10.1097/iae.0000000000002632 · 2020 · External reference

Mediterranean diet and incidence of advanced age-related macular degeneration: the EYE-RISK Consortium

10.1016/j.ophtha.2018.08.006 · 2019 · External reference

Retinal imaging with polarization-sensitive optical coherence tomography and adaptive optics

10.1364/oe.17.021634 · 2009 · External reference

Volumetric retinal imaging with ultrahigh-resolution spectral-domain optical coherence tomography and adaptive optics using two broadband light sources

10.1364/oe.17.004095 · 2009 · External reference

Two concepts for ultra-high-resolution polarization-sensitive optical coherence tomography with a single camera

10.1364/josaa.458631 · 2022 · External reference

Non-invasive retinal blood vessel wall measurements with polarization-sensitive optical coherence tomography for diabetes assessment: a quantitative study

10.3390/biom13081230 · 2023 · External reference

Hypertension-associated changes in retinal blood vessel walls measured in vivo with polarization-sensitive optical coherence tomography

10.1016/j.optlaseng.2023.107838 · 2023 · External reference